|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Sonnet BioTherapeutics (NASDAQ: SONN) through any online brokerage.
The latest price target for Sonnet BioTherapeutics (NASDAQ: SONN) was reported by Chardan Capital on September 4, 2020. The analyst firm set a price target for 8.00 expecting SONN to rise to within 12 months (a possible 393.83% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Sonnet BioTherapeutics (NASDAQ: SONN) is $1.62 last updated Fri Jun 11 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Sonnet BioTherapeutics.
There is no upcoming split for Sonnet BioTherapeutics.
Sonnet BioTherapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.